Form 4: QuidelOrtho Director Receives Equity Grant

Evelyn S. Dilsaver, a Director at QuidelOrtho Corp, was granted 15,532 restricted stock units on June 25, 2026, vesting on June 25, 2027.

Summary

• Evelyn S. Dilsaver, a Director at QuidelOrtho Corp (QDEL), received a grant of 15,532 restricted stock units (RSUs) on June 25, 2026.
• These RSUs represent the right to receive one share of QuidelOrtho Corporation common stock per unit.
• The restricted stock units are scheduled to vest on June 25, 2027.
• The transaction was reported on June 29, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard equity grant to a director rather than a significant change in company performance or strategy.

Positives

• Director Evelyn S. Dilsaver received a significant equity grant, indicating continued investment and alignment with the company's long-term performance.
• The grant of 15,532 restricted stock units suggests confidence in the future value of QuidelOrtho Corporation's common stock.

Future Outlook

The vesting of the restricted stock units on June 25, 2027, suggests a forward-looking incentive tied to the company's performance over the next year.

Industry Context

StockSavvy.ai notes that equity grants to directors are a common practice in the healthcare and diagnostics industry, serving as a key component of executive compensation and a mechanism to align management's interests with those of shareholders.

Stakeholder Impact

• Shareholders: The equity grant aligns director incentives with shareholder value creation.
• Employees: May signal a positive outlook for the company, potentially impacting employee morale and retention.
• Management: Reinforces the compensation structure for key leadership.

Next Steps

• The restricted stock units will vest on June 25, 2027.

Key Dates

Keywords

QuidelOrtho Corp, QDEL, Form 4, Insider Trading, Equity Grant, Restricted Stock Units, Director Compensation, Securities Exchange Act